Top

Tag: Adaptive Biotechnologies


Mergers and Acquisitions

Adaptive Biotechnologies Announces Collaboration with Takeda for Minimal Residual Disease Measures

April 28, 2023

Via: Biopharm International

Adaptive Biotechnologies Corporation announced on April 12, 2023 that it has begun a translational collaboration with Takeda. Adaptive Biotechnologies will use its clonoSEQ Assay to assess minimal residue disease (MRD) to start with the development and commercialization of Takeda‚Äôs pipeline […]